Central nervous system nociceptive and sedative pathways

The central nervous system (CNS) nociceptive and sedative pathways encompass the integrated network of neurons and molecular signaling systems that process pain signals and regulate states of arousal. Nociceptive pathways involve the transmission of noxious stimuli from peripheral receptors through the spinal cord to the brain, where they are modulated by descending inhibitory systems such as the periaqueductal gray [1]. Sedative pathways primarily function by enhancing inhibitory neurotransmission, most notably through the GABAergic system, or by suppressing excitatory arousal centers in the brainstem and hypothalamus [2]. These pathways are not defined by a single molecular target but rather involve a variety of receptors including Mu-opioid receptors, GABA-A receptors, and NMDA receptors [3]. Drugs targeting these pathways, such as opioids and benzodiazepines, are essential for managing acute pain and inducing anesthesia, yet they pose significant risks including respiratory depression and potential for addiction [4]. Understanding the interplay between these pathways is crucial for developing safer analgesic and sedative therapies that minimize adverse effects on consciousness and vital functions [5].

Other names

CNS pain and arousal pathwaysNociceptive signaling systemCentral sedative pathwaysAscending and descending pain pathways

Modulation of synaptic transmission through agonism of inhibitory receptors (e.g., GABA-A, Mu-opioid) or antagonism of excitatory receptors (e.g., NMDA) within the CNS.